Zero Candida Technologies, Inc. (FRA:9L2)

Market Cap	2.31M
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.0975
Previous Close	0.0980
Day's Range	0.0975 - 0.0975
52-Week Range	0.0855 - 0.3160
Beta	n/a
RSI	55.32
Earnings Date	n/a

About Zero Candida Technologies

Zero Candida Technologies, Inc., a technology company, designs, develops, manufactures, and sells non-drug blue light therapy devices for the treatment of vulvo-vaginal candidiasis. It offers Zero Candida, a smart vaginal diagnostic device that collects and transmits treatment data to the attending physician in real time for assessment, treatment, personalization, and monitoring. The company is headquartered in Vancouver, Canada.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Country: Canada
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 9L2